Humanized Mice Model Market to Grow at a Formidable Rate through 2025
Innovations in mice models
is expected to drive the growth of global humanized mice model market during
the forecast period
According
to TechSci Research report, “Global Humanized
Mice Model Market By Service (Breeding, Cryopreservation, Others), By Type
(Inbred Mice, Outbred Mice, Genetically Engineered Mice, Others), By Immune
Checkpoints (CD47, CD34, PBMC, Others), By Technology (Crispr/Cas9, Microinjection,
Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies), By
Application (Oncology Studies, Immunology and Inflammation Studies, Others), By
End-use (Companies, Organizations, Academic and Research Institutes, Contract
Research Organizations), By Region, Forecast & Opportunities, 2025”, the global humanized mice model market is expected to grow
at an impressive CAGR during the forecast period on account of the growing consumption
of personalized medicines. In addition to this, expanding pipeline of
pharmaceutical and biopharmaceutical companies across the globe is expected to
propel the market growth over the next few years. Besides, growing application
of mice for research purpose such as for immunology and inflammation studies,
central nervous system studies, among others, is further expected to fuel the
market growth. Moreover, growing demand for mice model in cancer research so
that genetic basis of tumor development and cancer progression can be studied, is
further driving the market growth. However, there are certain factors that
might act as major impediments to the growth of global mice model market during
the forecast period such as growing concern for the wellbeing of animals coupled
with increasing awareness pertaining to animal rights.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on " Global
Humanized Mice Model market"
https://www.techsciresearch.com/report/humanized-mice-model-market/4827.html
The global humanized mice model market is segmented based on service,
type, immune checkpoints, technology, application, end use, company, company
and region. Based on application, the market can be split into oncology
studies, immunology and inflammation studies, diabetes studies, cardiovascular
studies, central nervous system studies and other disease studies. Here, the oncology
studies segment is expected to dominate the market during the forecast period.
This dominance can be attributed to growing cancer research activities across
the globe. Additionally, rapid innovation in mice models in order to meet the
requirements for cancer research, is further contributing to the growing trend.
Based on technology, the market can be fragmented into Crispr/Cas9, microinjection,
embryonic stem cell injection, nuclear transfer and other technologies. Among
these, the Crispr/Cas9 technology segment is expected to register high growth
in the market in the next 5 years. This high growth of this segment can
primarily be attributed to numerous advantages it offers such as ease of
design, high efficiency, and relatively low cost. Owing to these advantages, CRISPR
is the most widely used technique, which is leading to large market share of
this segment.
Charles River Laboratories, International, Inc., The Jackson Laboratory,
Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan Laboratories,
Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic,
Inc., Genoway, Creative Biolabd, Horizon Discovery Group, Ingenious Targeting
Laboratory, Biocytogen, Taconic Biosciences and others are some of the leading
players operating in global humanized mice model market. The companies operating
in the market are coming with new developments in order to boost their market
share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4827
Customers can also
request for 10% free customization on this report.
“North America is expected to dominate in
the humanized mice model market during the forecast period owing to surging
focus on biomedical research in the region, predominantly in United States.
Additionally, rising demand for monoclonal antibody production is further
expected to spur the market growth. Furthermore, presence of large market
players in the region are expected to create lucrative opportunities for the
market growth over the coming years.” said Mr. Karan Chechi, Research
Director with TechSci Research, a research based global management consulting firm.
“Global Humanized Mice Model Market By Service (Breeding,
Cryopreservation, Others), By Type (Inbred Mice, Outbred Mice, Genetically
Engineered Mice, Others), By Immune Checkpoints (CD47, CD34, PBMC, Others), By
Technology (Crispr/Cas9, Microinjection, Embryonic Stem Cell Injection, Nuclear
Transfer, Other Technologies), By Application (Oncology Studies, Immunology and
Inflammation Studies, Others), By End-use (Companies, Organizations, Academic
and Research Institutes, Contract Research Organizations), By Region, Forecast & Opportunities, 2025”, has
evaluated the future growth potential of global humanized mice model market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in global humanized mice model market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email:
[email protected]